NeuroVive: Secured Financing

Research Note



NeuroVive has raised SEK 67m through the preferential rights issue, subscribed to 90%. With this, the company has secured financing until the middle of 2021.


Gergana Almquist

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.